🔥🐔 BizChicken 🐔🔥
Companies Similar to Unicycive Therapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Halozyme Therapeutics, Inc.
ENHANZE drug delivery technology
Halozyme Therapeutics, Inc. is a biopharma technology platform company specializing in enabling subcutaneous delivery of biologics using its patented ENHANZE technology. The company operates in the United States and internationally, offering products such as Hylenex recombinant and developing treatments for various medical conditions including lymphomas and immunodeficiency disorders.
Symbol: HALO
Recent Price: $47.99
Industry: Biotechnology
CEO: Dr. Helen I. Torley M.B. Ch. B., M.R.C.P.
Sector: Healthcare
Employees: 373
Address: 11388 Sorrento Valley Road, San Diego, CA 92121
Phone: 858 794 8889
Last updated: 2024-12-31
Oncternal Therapeutics, Inc.
zilovertamab, ONCT-216, ONCT-808, ONCT-534
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.
Symbol: ONCT
Recent Price: $0.53
Industry: Biotechnology
CEO: Dr. James B. Breitmeyer M.D., Ph.D.
Sector: Healthcare
Employees: 27
Address: 12230 El Camino Real, San Diego, CA 92130
Phone: 858 434 1113
Last updated: 2024-12-31
Reneo Pharmaceuticals, Inc.
REN001
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing therapies for patients with rare genetic mitochondrial diseases. Its primary product, REN001, is a selective peroxisome proliferator-activated receptor delta agonist currently in clinical trials.
About | About | About | Management | Directors | Contact | Contact | Careers | Careers | About | About | About
Symbol: RPHM
Recent Price: $18.20
Industry: Biotechnology
CEO: Mr. Gregory J. Flesher
Sector: Healthcare
Employees: 8
Address: 18575 Jamboree Road, Irvine, CA 92612
Phone: 619 733 3852
Last updated: 2024-12-31
Reviva Pharmaceuticals Holdings, Inc.
RP5063
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing next-generation therapeutics for unmet medical needs, particularly in central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases.
Symbol: RVPH
Recent Price: $1.81
Industry: Biotechnology
CEO: Dr. Laxminarayan Bhat Ph.D.
Sector: Healthcare
Employees: 15
Address: 19925 Stevens Creek Boulevard, Cupertino, CA 95014
Phone: 408 501 8881
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
Cidara Therapeutics, Inc.
rezafungin acetate
Cidara Therapeutics, Inc. is a biotechnology company focused on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology. Their lead product candidate is rezafungin acetate, a novel echinocandin antifungal for treating invasive fungal infections.
Symbol: CDTX
Recent Price: $25.25
Industry: Biotechnology
CEO: Dr. Jeffrey L. Stein Ph.D.
Sector: Healthcare
Employees: 69
Address: 6310 Nancy Ridge Drive, San Diego, CA 92121
Phone: 858 752 6170
Last updated: 2024-12-31
Coherus BioSciences, Inc.
UDENYCA
Coherus Bio Sciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. It markets UDENYCA and develops various biosimilar and immuno-oncology products.
Symbol: CHRS
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Dennis M. Lanfear
Sector: Healthcare
Employees: 306
Address: 333 Twin Dolphin Drive, Redwood City, CA 94065
Phone: 650 649 3530
Last updated: 2024-12-31
Heron Therapeutics, Inc.
SUSTOL, CINVANTI, ZYNRELEF
Heron Therapeutics, Inc. is a biotechnology company focused on developing treatments to address unmet patient needs, utilizing its proprietary Biochronomer drug delivery technology.
About | Management | Directors | About | Contact | Careers | About | Careers | Jobs | Careers
Symbol: HRTX
Recent Price: $1.51
Industry: Biotechnology
CEO: Mr. Craig Alexander Collard
Sector: Healthcare
Employees: 126
Address: 4242 Campus Point Court, San Diego, CA 92121
Phone: 858 251 4400
Leadership
- Adam Morgan, Chairman
- Sharmila Dissanaike, M.D., FACS, FCCM, Director
- Craig Johnson, Lead Independent Director
- Susan Rodriguez, Director
- Christian Waage, Director
- Craig Collard, Director
- Brett Fleshman, Chief Business Officer
Last updated: 2024-12-31
Inozyme Pharma, Inc.
INZ-701
Inozyme Pharma, Inc. is a biopharmaceutical company focused on the development of therapeutics for rare disease conditions involving abnormal mineralization, particularly targeting ENPP1 and ABCC6 deficiencies.
Symbol: INZY
Recent Price: $2.82
Industry: Biotechnology
CEO: Dr. Douglas A. Treco Ph.D.
Sector: Healthcare
Employees: 59
Address: 321 Summer Street, Boston, MA 02210
Phone: 857 330 4340
Leadership
- Doug Treco, Ph.D., CEO, Chairman of Board of Directors
- Gayle Gironda, Senior Vice President and Chief People Officer
- Kurt Gunter, M.D., Senior Vice President and Chief Medical Officer
- Soojin Kim, Ph.D., Senior Vice President and Chief Technical Operations Officer
- Yves Sabbagh, Ph.D., Senior Vice President and Chief Scientific Officer, Chair of the Scientific Advisory Board
- Sanjay S. Subramanian, M.S., MBA, Senior Vice President and Chief Financial Officer
- Matt Winton, Ph.D., Senior Vice President and Chief Operating Officer
- Axel Bolte, MBA, Co-founder, Senior Advisor and Member of Board of Directors
- David Thompson, M.A., M.S., Ph.D., Senior Advisor, Member of Scientific Advisory Board
- Sarah Bhagat, Ph.D., Director
- Reinaldo M. Diaz, MBA, Director
- Martin Edwards M.D., MBA, Director
- Erik Harris, MBA, Director
- Rob Hopfner, Rph, Ph.D., MBA, Director
- Edward Mathers, Director
- Lynne Sullivan, MST, Director
Last updated: 2024-12-31
MediciNova, Inc.
MN-166 (ibudilast)
Medici Nova, Inc. is a biopharmaceutical company focused on developing novel therapeutics for serious diseases with unmet medical needs, including neurologic disorders, fibrotic diseases, and solid tumor cancers.
Symbol: MNOV
Recent Price: $2.11
Industry: Biotechnology
CEO: Dr. Yuichi Iwaki M.D., Ph.D.
Sector: Healthcare
Employees: 13
Address: 4275 Executive Square, La Jolla, CA 92037
Phone: 858 373 1500
Leadership
- Yuichi Iwaki, M.D., Ph.D., President and Chief Executive Officer, and Founder
- Kazuko Matsuda, M.D., Ph.D, MPH, Chief Medical Officer
- David H. Crean, Ph.D., Chief Business Officer
- Jason J. Kruger, CPA (inactive), Chief Financial Officer
- Hideki Nagao, Member of the Board of Directors
- Carolyn Beaver, Member of the Board of Directors
- Nicole Lemerond, CFA, Member of the Board of Directors
Last updated: 2024-12-31
Rani Therapeutics Holdings, Inc.
Rani Pill
Rani Therapeutics Holdings, Inc. is a clinical stage biotherapeutics company focused on developing orally administered biologics with its Rani Pill platform, aimed at replacing subcutaneous or IV injections. The company has multiple products in various stages of development targeting conditions like neuroendocrine tumors, psoriatic arthritis, osteoporosis, growth hormone deficiency, hypoparathyroidism, and type 2 diabetes.
Leadership | Leadership | Contact | Contact | Careers | Careers | Careers
Symbol: RANI
Recent Price: $1.48
Industry: Biotechnology
CEO: Mr. Talat Imran
Sector: Healthcare
Employees: 140
Address: 2051 Ringwood Avenue, San Jose, CA 95131
Phone: 408 457 3700
Leadership
- Talat Imran, Chief Executive Officer
- Mir Imran, Founder and Executive Chairman
- Mir Hashim, Chief Scientific Officer
- Svai Sanford, Chief Financial Officer
- Eric Groen, General Counsel
- Kate McKinley, Chief Business Officer
- Jacques Van Dam, Vice President, Medical Affairs
- Alireza Javadi, VP of Technical Operations
- Betsy Gutierrez, Vice President, Quality Assurance
- Bella Vazquez, Vice President, Human Resources
- Kyle Horlen, VP of Nonclinical Development & Safety Assessment
- Arvinder Dhalla, Vice President, Clinical Development
- Andrew Farquharson, Managing Director, VHM and InCube Ventures
- Maulik Nanavaty, CEO of Anumana
- Jean-Luc Butel, Director at Takeda, Novo Holdings, and SG Innovate
- Laureen DeBuono, Managing Partner, FLG Partners
- Dennis Ausiello, Director of CATCH & Former Chief of Medicine, Mass General
- Lisa Rometty, President, CVS Kidney Care
Last updated: 2024-12-31
Rocket Pharmaceuticals, Inc.
Gene Therapies
Rocket Pharmaceuticals, Inc. is a biotechnology company focused on developing gene therapies for rare and devastating diseases, with multiple clinical-stage programs targeting disorders such as fanconi anemia, leukocyte adhesion deficiency-I, pyruvate kinase deficiency, and Danon disease.
Symbol: RCKT
Recent Price: $12.03
Industry: Biotechnology
CEO: Dr. Gaurav D. Shah M.D.
Sector: Healthcare
Employees: 268
Address: 9 Cedarbrook Drive, Cranbury, NJ 08512
Phone: 609 659 8001
Last updated: 2024-12-31
Renovaro Biosciences Inc.
RENB-HV-01, RENB-HV-12, RENB-HB-01, RENB-DC-11, RENB-DC-12-XX, RENB-HV-21
Renovaro Biosciences Inc. is a pre-clinical stage biotechnology company focused on R&D of pharmaceutical and biological products for treating HIV, HBV, and cancer in the U.S. The company has a robust product pipeline and strategic partnerships, and was formerly known as Enochian Biosciences, Inc.
Symbol: RENB
Recent Price: $0.87
Industry: Biotechnology
CEO: Mr. David H. Weinstein
Sector: Healthcare
Employees: 25
Address: 2080 Century Park East, Los Angeles, CA 90067
Phone: 305 918 1980
Last updated: 2024-12-31
Rockwell Medical, Inc.
Triferic Dialysate and Triferic AVNU
Rockwell Medical, Inc. is a biopharmaceutical company that focuses on therapies and products for the treatment of iron deficiency and hemodialysis, targeting end-stage renal disease and chronic kidney disease.
Symbol: RMTI
Recent Price: $2.05
Industry: Drug Manufacturers - Specialty & Generic
CEO: Dr. Mark Strobeck Ph.D.
Sector: Healthcare
Employees: 237
Address: 30142 South Wixom road, Wixom, MI 48393
Phone: 248 960 9009
Last updated: 2024-12-31
RenovoRx, Inc.
Renovo Gem
Renovo Rx, Inc. is a clinical-stage biopharmaceutical company focusing on developing therapies for the treatment of solid tumors, with its lead product candidate, Renovo Gem, in Phase III clinical trials for locally advanced pancreatic cancer.
Leadership | Directors | About | Contact | Careers | Careers | Jobs | Careers | Careers | Jobs | Careers | Careers | About | About | About | About | About | About
Symbol: RNXT
Recent Price: $1.39
Industry: Biotechnology
CEO: Mr. Shaun R. Bagai
Sector: Healthcare
Employees: 8
Address: 4546 El Camino Real, Los Altos, CA 94022
Phone: 650 284 4433
Leadership
- Shaun R. Bagai, Director and Chief Executive Officer
- Ramtin Agah, MD, Chairman, Chief Medical Officer, and Founder
- Leesa Gentry, Chief Clinical Officer
- Ronald B. Kocak, CPA, VP Controller and Principal Accounting Officer
- Ryan Witt, Senior Vice President, Head of Corporate Strategy and Partnerships
- Imtiaz Qureshi, MD, Director of Imaging
- Angela Macfarlane, CEO of Perceive Biotherapeutics, Inc.
- Laurence J. Marton, MD, Director
- Una S. Ryan, PhD, OBE, Director
- Robert J. Spiegel, Director
Last updated: 2024-12-31
Rezolute, Inc.
RZ358
Rezolute, Inc. is a clinical stage biopharmaceutical company focused on developing transformative therapies for metabolic diseases related to chronic glucose imbalance. Its lead product, RZ358, is aimed at treating congenital hyperinsulinism.
Symbol: RZLT
Recent Price: $4.89
Industry: Biotechnology
CEO: Mr. Nevan Charles Elam J.D.
Sector: Healthcare
Employees: 59
Address: 201 Redwood Shores Parkway, Redwood City, CA 94065
Phone: 650 206 4507
Last updated: 2024-12-31
Surrozen, Inc.
SZN-043, SZN-1326
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to modulate the Wnt pathway for tissue repair and regeneration. Its products focus on treating severe liver disease and modulating Wnt signaling in intestinal tissue.
Symbol: SRZN
Recent Price: $13.46
Industry: Biotechnology
CEO: Mr. Craig C. Parker M.B.A.
Sector: Healthcare
Employees: 42
Address: 171 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 650 489 9000
Leadership
- Craig Parker, MBA, Chief Executive Officer
- Charles Williams, Chief Operating Officer and Chief Financial Officer
- Yang Li, PhD, Executive Vice President, Research
- David J. Woodhouse, PhD, Chairman, Surrozen / Chief Executive Officer, NGM Biopharmaceuticals
- Anna Berkenblit, MD, MMS, Chief Scientific and Medical Officer at the Pancreatic Cancer Action Network
- Chris Chai, Venture Partner, SR One
- Mary Haak-Frendscho, Ph.D., President and Chief Executive Officer, Spotlight Therapeutics
- Shao-Lee Lin, MD, PhD, Co-founder and Chief Executive Officer, ACELYRIN, INC.
- Mace Rothenberg, M.D., Independent Board Member
- Eric Bjerkholt, CFO of Chinook Therapeutics
Last updated: 2024-12-31
Unicycive Therapeutics, Inc.
Renazorb, UNI 494
Unicycive Therapeutics is a biotech company developing novel therapies for kidney diseases in the United States, focusing on treatments for hyperphosphatemia and acute kidney injury.
Symbol: UNCY
Recent Price: $0.58
Industry: Biotechnology
CEO: Dr. Shalabh K. Gupta M.D., MPA
Sector: Healthcare
Employees: 14
Address: 4300 El Camino Real, Los Altos, CA 94022
Phone: 650 351 4495
Last updated: 2024-11-08
ProKidney Corp.
Renal Autologous Cell Therapy
Pro Kidney Corp. is a clinical-stage biotechnology company focused on developing cellular therapy candidates, including Renal Autologous Cell Therapy, for the treatment of diabetic kidney disease and congenital anomalies of the kidney and urinary tract.
Symbol: PROK
Recent Price: $1.75
Industry: Biotechnology
CEO: Dr. Bruce Culleton M.D.
Sector: Healthcare
Employees: 163
Address: 2000 Frontis Plaza Blvd., Winston-Salem, NC 27103
Phone: 336 999 7028
Leadership
- Bruce Culleton, MD, Chief Executive Officer
- James Coulston, CPA, Chief Financial Officer
- Todd C. Girolamo, JD, MBA, Chief Legal Officer and Secretary
- Nikhil Pereira-Kamath, Chief Business Officer
- Darin J. Weber, PhD, Chief Regulatory Officer
- Carla Poulson, Chief People Officer
- Ulrich Ernst, PhD, EVP, Technical Operations
- Emily Butler, PhD, SVP, Biometrics
- Joseph Stavas, MD, MPH, SVP, Interventional Procedures and Patient Safety
- Lucio Tozzi, SVP, Global Clinical Operations
- Richard Williams, SVP, Information Technology
Last updated: 2024-12-31
Terns Pharmaceuticals, Inc.
TERN-101, TERN-201, TERN-501, TERN-601
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and obesity, incorporating products like TERN-101, TERN-201, TERN-501, and TERN-601.
About | Contact | Careers | Careers | Careers | About | About | Careers | Culture | About | Leadership | About
Symbol: TERN
Recent Price: $7.15
Industry: Biotechnology
CEO: Ms. Amy L. Burroughs M.B.A.
Sector: Healthcare
Employees: 66
Address: 1065 East Hillsdale Boulevard, Foster City, CA 94404
Phone: 650 525 5535
Last updated: 2024-11-08